Scholars Central

Research articlePublished 24 Dec 2012

Significance of Biotransformation in Drug Discovery and Development

Authors: Selvan Ravindran, Sudipta Basu, Prashant Surve, Ganesh Lonsane, Navya Sloka

Journal of Biotechnology & Biomaterials

Volume 3 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biotransformation is a process by which organic compounds are transformed from one form to another, aided by organisms such as bacteria, fungi and enzymes. Biotransformations are used as a valuable strategy to build molecules, similar to parent drug in the drug discovery programme. Biotransformations can also be used to synthesize compounds or materials, if synthetic approaches are challenging. Microbial biotransformations or microbial biotechnology are extensively used to generate metabolites in bulk amounts. Biotransformation approaches and synthetic methods in tandem provide a source for generating compounds around core structures, which can be screened for various biological activity studies. These studies help in screening and advancing the compounds, through various stages of drug discovery programme. Hence, biotransformation experiments can be effectively utilized to synthesize more compounds. In the present study, a sulfonylurea urea drug was incubated with microsomal proteins to produce metabolites. Liquid chromatography is used to separate the formed metabolites and the parent drug. Fragmentation pattern obtained from the mass spectrum is utilized to identify the biotransformation site in the molecule, which is the metabolic soft spot. Identified new metabolites are structurally similar to parent drugs, implying the possibility of better therapeutic effects. Few phase-I metabolites and phase-II metabolites are predicted with the help of liquid chromatography and mass spectrometry data. Synthesis of these identified, as well as predicted metabolites, and subjecting them to various pharmacological and toxicological studies will help to generate new materials with valuable therapeutic properties.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Selvan Ravindran”
  • BylineArticles whose byline prints “Sudipta Basu”
  • BylineArticles whose byline prints “Prashant Surve”
  • BylineArticles whose byline prints “Ganesh Lonsane”
  • BylineArticles whose byline prints “Navya Sloka”